These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 115007)

  • 41. The mode of action of anti-inflammatory drugs.
    Vane JR; Botting RM
    Postgrad Med J; 1990; 66 Suppl 4():S2-17. PubMed ID: 2126623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway.
    Siegel MI; McConnell RT; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):3774-8. PubMed ID: 115007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arachidonate metabolism via lipoxygenase and 12L-hydroperoxy-5,8,10,14-icosatetraenoic acid peroxidase sensitive to anti-inflammatory drugs.
    Siegel MI; McConnell RT; Porter NA; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):308-12. PubMed ID: 6767237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The combined effects of sodium salicylate, aspirin and indomethacin on the metabolism of arachidonic acid in human platelets.
    Dahl ML; Uotila P
    Prostaglandins Leukot Med; 1984 Oct; 16(1):95-107. PubMed ID: 6440154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity.
    Cerletti C
    Int J Tissue React; 1985; 7(4):309-12. PubMed ID: 3934097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salicylate fails to prevent the inhibitory effect of 5,8,11,14-eicosatetraynoic acid on human platelet cyclo-oxygenase and lipoxygenase activities.
    Cerletti C; Livio M; Doni MG; De Gaetano G
    Biochim Biophys Acta; 1983 Aug; 759(1-2):125-7. PubMed ID: 6411131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indomethacin and aspirin abolish prostaglandin release from the spleen.
    Ferreira SH; Moncada S; Vane JR
    Nat New Biol; 1971 Jun; 231(25):237-9. PubMed ID: 5284362
    [No Abstract]   [Full Text] [Related]  

  • 48. Aspirin selectively inhibits prostaglandin production in human platelets.
    Smith JB; Willis AL
    Nat New Biol; 1971 Jun; 231(25):235-7. PubMed ID: 5284361
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.
    Vane JR
    Nat New Biol; 1971 Jun; 231(25):232-5. PubMed ID: 5284360
    [No Abstract]   [Full Text] [Related]  

  • 50. Some quantitative temporal characteristics of carrageenin-induced pleurisy in the rat.
    Vinegar R; Truax JF; Selph JL
    Proc Soc Exp Biol Med; 1973 Jul; 143(3):711-4. PubMed ID: 4719457
    [No Abstract]   [Full Text] [Related]  

  • 51. Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins.
    Hamberg M; Svensson J; Samuelsson B
    Proc Natl Acad Sci U S A; 1974 Oct; 71(10):3824-8. PubMed ID: 4530264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets.
    Hamberg M; Samuelsson B
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3400-4. PubMed ID: 4215079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New aspects of chemotaxis. Specific target-cell attraction by lipid and lipoprotein fractions of Escherichia coli chemotactic factor.
    Tainer JA; Turner SR; Lynn WS
    Am J Pathol; 1975 Nov; 81(2):401-10. PubMed ID: 1103633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of indomethacin.
    Alván G; Orme M; Bertilsson L; Ekstrand R; Palmér L
    Clin Pharmacol Ther; 1975 Sep; 18(3):364-73. PubMed ID: 1100305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative studies of the pathway to acute carrageenan inflammation.
    Vinegar R; Truax JF; Selph JL
    Fed Proc; 1976 Nov; 35(13):2447-56. PubMed ID: 976489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin.
    Baenziger NL; Dillender MJ; Majerus PW
    Biochem Biophys Res Commun; 1977 Sep; 78(1):294-301. PubMed ID: 907679
    [No Abstract]   [Full Text] [Related]  

  • 57. Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.
    Goetzl EJ; Woods JM; Gorman RR
    J Clin Invest; 1977 Jan; 59(1):179-83. PubMed ID: 830662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation.
    Moncada S; Gryglewski RJ; Bunting S; Vane JR
    Prostaglandins; 1976 Nov; 12(5):715-37. PubMed ID: 824686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets.
    Turner SR; Tainer JA; Lynn WS
    Nature; 1975 Oct; 257(5528):680-1. PubMed ID: 810723
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.